FNY Investment Advisers, LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison

A Look at the Changing Landscape of Fund Holdings

In the financial world, fund holdings play a crucial role in assessing a company's investments and overall portfolio strategy. These holdings are disclosed in the form of a 13F report, which provides detailed information on the stock positions held by institutional investment managers. FNY Investment Advisers, LLC recently released its Q2 2023 and Q3 2023 13F holdings, offering a glimpse into their changing investment landscape. Let's take a closer look at some of the significant changes that occurred during this period.

ACTIVISION BLIZZARD ORD (ATVI)

One of the most notable changes in FNY Investment Advisers' holdings is the substantial increase in their holdings of ACTIVISION BLIZZARD ORD (ATVI). In Q2 2023, FNY Investment Advisers held 19,272 shares of ATVI, with a value of $1.6 million. However, in Q3 2023, their position skyrocketed to 316,811 shares, with a value of $29 million. This represents a staggering 98.2% increase in shares held.

HORIZON THERAPEUTICS PUBLIC ORD

Another significant change in FNY Investment Advisers' holdings is the increase in their position in HORIZON THERAPEUTICS PUBLIC ORD. In Q2 2023, they held 44,395 shares, valued at $4.6 million. However, in Q3 2023, their position grew to 144,340 shares, with a value of $16 million. This represents a 99.6% increase in shares held.

DANAHER ORD (DHR)

FNY Investment Advisers completely divested their holdings in DANAHER ORD (DHR) in Q2 2023. They held no shares of the company during this period. However, in Q3 2023, they re-entered the market with a position of 56,450 shares, valued at $12 million.

SEAGEN ORD (SGEN)

FNY Investment Advisers reduced their position in SEAGEN ORD (SGEN) during the Q2 2023 to Q3 2023 period. In Q2 2023, they held 11,934 shares, with a value of $2.3 million. However, in Q3 2023, their position decreased to 35,300 shares, valued at $7 million. This represents a 99.7% decrease in shares held.

KELLANOVA ORD (K)

FNY Investment Advisers acquired a new position in KELLANOVA ORD (K) during the Q2 2023 to Q3 2023 period. They held no shares of the company in Q2 2023 but accumulated 105,600 shares, with a value of $5 million, in Q3 2023.

RESMED ORD (RMD)

FNY Investment Advisers increased their position in RESMED ORD (RMD) during the Q2 2023 to Q3 2023 period. In Q2 2023, they held 2,000 shares, valued at $437,000. However, in Q3 2023, their position grew to 34,200 shares, with a value of $342,000. This represents a 98.8% increase in shares held.

VMWARE CL A ORD (VMW)

FNY Investment Advisers also reduced their position in VMWARE CL A ORD (VMW) during the Q2 2023 to Q3 2023 period. In Q2 2023, they held 12,464 shares, with a value of $1.7 million. However, in Q3 2023, their position decreased to 27,464 shares, valued at $4 million. This represents a 99.7% decrease in shares held.

ARAMARK ORD (ARMK)

FNY Investment Advisers entered the ARAMARK ORD (ARMK) market during the Q2 2023 to Q3 2023 period. They held no shares of the company in Q2 2023 but acquired 139,000 shares, with a value of $3 million, in Q3 2023.

CAPRI HOLDINGS ORD (CPRI)

FNY Investment Advisers also entered the CAPRI HOLDINGS ORD (CPRI) market during the Q2 2023 to Q3 2023 period. They held no shares of the company in Q2 2023 but acquired 59,600 shares, valued at $3 million, in Q3 2023.

These are just a few examples of the significant changes in FNY Investment Advisers' Q2 2023 to Q3 2023 13F holdings. The data provided sheds light on the dynamic nature of fund management, as investment managers continuously adjust their positions based on market conditions and evolving investment strategies. As the financial landscape continues to evolve, it will be interesting to see how these changes impact the success and performance of FNY Investment Advisers and their clients.

Disclaimer: The information provided in this article is for educational purposes only and should not be considered as financial advice. Investing in the stock market carries risks, and individuals should conduct thorough research and seek professional guidance before making any investment decisions.